Concepedia
Statistics
Publications
37
Citations
942
H-Index
19
Active since
2014
Affiliations
Jiangnan University(Current)
State Key Laboratory of Food Science and Technology
Northeast Agricultural University
Shanghai Innovative Research Center of Traditional Chinese Medicine
Wuxi No.2 People's Hospital
Shenglong Zhu is an author at Jiangnan University specializing in life sciences, cell signaling, and pharmacology.
Publications per year
2014–2025
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway
Shenglong Zhu, Lei Ma, Yunzhou Wu et al. · Acta Biochimica et Biophysica Sinica · 2014 · 92 citations
Life Sciences, Biochemistry, Pharmacology +17
FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy
Shenglong Zhu, Yunzhou Wu, Xianlong Ye et al. · Molecular and Cellular Biochemistry · 2016 · 70 citations
Life Sciences, Biochemistry, Cell Biology +12
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yikuan Wu, Zhengnan Ren, Shenglong Zhu et al. · Acta Pharmacologica Sinica · 2021 · 58 citations · Full text
Life Sciences, Biochemistry, Pharmacology +9
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Yunzhou Wu, Jinjiao He, Ying An et al. · Journal of Pharmacological Sciences · 2016 · 46 citations · Full text
Life Sciences, Immunology, Oncology +17
Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1–Arih2 axis
Xuan Jiang, Siyu Ji, Feng‐Lai Yuan et al. · Journal of Cachexia Sarcopenia and Muscle · 2022 · 44 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
1–5 of 37